Skip to main content
Advertisement
Advertisement

JAGX

JAGX logo

Jaguar Health, Inc.

7.06
USD
Sponsored
-1.85
-20.76%
Sep 24, 15:59 UTC -4
Closed
exchange

Pre-Market

7.04

-0.02
-0.27%

JAGX Earnings Reports

Positive Surprise Ratio

JAGX beat 13 of 31 last estimates.

42%

Next Report

Date of Next Report
Nov 12, 2026
Estimate for Q3 26 (Revenue/ EPS)
$4.94M
/
-$1.19
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
+60.39%
/
-99.46%

Jaguar Health, Inc. earnings per share and revenue

On Aug 12, 2026, JAGX reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -1.51 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 4.33 million, with a --% difference.
Looking ahead to Q3 26, 3 analysts forecast an EPS of -1.19 USD, with revenue projected to reach 4.94 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Jaguar Health, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Nov 12, 2026.
Based on 3 analysts, Jaguar Health, Inc. is expected to report EPS of -$1.19 and revenue of $4.94M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement